What does NeurAxis, Inc. do?
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with…
What is NeurAxis, Inc.'s P/E and P/B ratio?
NeurAxis, Inc. has a P/E ratio of -9.7 and a P/B ratio of 14.17.
What is NeurAxis, Inc.'s debt-to-equity ratio?
NeurAxis, Inc. has a debt-to-equity ratio of 0.04.
How much does NeurAxis, Inc. owe compared with what it owns?
NeurAxis, Inc. owes $0.33 for every $1 it owns (balance sheet Jun 2026), which is low.
What is NeurAxis, Inc.'s Positivity rank?
NeurAxis, Inc. is ranked #5,938 of 6,774 companies globally and #3,335 of 4,000 in United States on PositoAI, with a Positivity Score of 13,805.
Does NeurAxis, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for NeurAxis, Inc..
Where can I read the latest news about NeurAxis, Inc.?
Recent headlines about NeurAxis, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does NeurAxis, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of NeurAxis, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.